You are here: Industry Insights > Immuno-Oncology

News List

Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor en-cphi.cn
April 03, 2019
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Phase 1/2 immuno-oncology trial in patients with newly diagnosed glioblastoma (GBM) has completed its enrollment three months ahead of schedule.
Immuno-Oncology Company Elicio Therapeutics Launches with Novel Vaccine & Immunotherapy Platform to Treat an Array of Cancers pharmafocusasia
March 28, 2019
Elicio Therapeutics, a next generation immuno-oncology company, engineering therapies for cancer killing immune responses, launched today and announced the appointment of Robert Connelly as CEO. Elicio is developing precision vaccines, immuno stimulators
Roche's I-O drug Tecentriq picks up key first-in-class breast cancer nod! fiercepharma
March 12, 2019
In a first for the immuno-oncology field, Roche’s Tecentriq has a big new approval in breast cancer.
Ligand Announces OmniAb Partnership with Genagon Therapeutics americanpharmaceuticalreview
February 14, 2019
Ligand Pharmaceuticals has entered into a worldwide OmniAb partnership with Genagon Therapeutics AB, an immuno-oncology focused biotech located in Sweden.....
Merck's Keytruda looks to zoom past Opdivo with fast head and neck cancer review fiercepharma
February 12, 2019
Merck & Co.’s Keytruda is duking it out with Bristol-Myers Squibb’s Opdivo in the head and neck cancer marketplace, but Keytruda just took one step toward a green light that would give it a big edge.
Ferring Appoints Lead to New U.S. Oncology Division americanpharmaceuticalreview
January 25, 2019
Ferring Pharmaceuticals has appointed Sophie Opdyke, Pharm.D., MBA as Vice President, General Manager, Oncology, effective immediately. She most recently served as Vice President, Immuno-Oncology Lead at Pfizer.....
I-Mab Biopharma gets USFDA IND nod for antibody TJD5 biospectrumasia
January 24, 2019
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases...
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal expressbpd
January 09, 2019
The two companies said the new arrangement would give Sanofi increased flexibility to advance its early-stage immuno-oncology pipeline, while Regeneron retains all rights to its other immuno-oncology discovery and development programmes
Sanofi revises immuno-oncology deal with Regeneron pharmaceutical-technology
January 08, 2019
Sanofi and Regeneron Pharmaceuticals have revised a global immuno-oncology discovery and development agreement to develop new treatments for cancer......
Takeda strikes three new immuno-oncology deals pharmaphorum
January 07, 2019
Takeda is upping its commitment to cancer after its Shire takeover with the announcement of three new research collaborations in immuno-oncology.....

Previous page 1 2 3 4 5 6 7 8 9 10 Next page